The RAF/MEK/ERK pathway will also induce the expression of cytokines and cytokine receptors which can alter the growth properties of cancer cells [8] and the drug- resistance of breast cancer cells [8–12]. The gene discussed is MAP2K7; the disease is breast cancer.